Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
12,586,921
-
Total 13F shares
-
5,034,489
-
Share change
-
+758,668
-
Total reported value
-
$39,316,245
-
Price per share
-
$7.76
-
Number of holders
-
29
-
Value change
-
+$4,704,467
-
Number of buys
-
13
-
Number of sells
-
6
Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) as of Q1 2025
As of 31 Mar 2025,
Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,034,489 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, FRED ALGER MANAGEMENT, LLC, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, Ikarian Capital, LLC, BVF INC/IL, ORBIMED ADVISORS LLC, Cable Car Capital, LP, Woodline Partners LP, BOOTHBAY FUND MANAGEMENT, LLC, and VANGUARD GROUP INC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.